Literature DB >> 9462818

Avoidable cancers in the Nordic countries. Tobacco smoking.

L Dreyer1, J F Winther, E Pukkala, A Andersen.   

Abstract

Active smoking is causally associated with cancers of the lung, larynx, oral cavity, pharynx, oesophagus, pancreas, renal parenchyma, renal pelvis and urinary bladder, and passive smoking appears to be causally associated with cancer of the lung. Information on smoking habits for the years 1965, 1975 and 1985 shows that more men than women in the Nordic countries were current smokers. The rates of women were stable over time and those of men were decreasing, approaching those of women. Lung cancer, in particular, is strongly associated with active smoking: by increasing the number of cigarettes smoked per day (lifelong) to 5, 10, 20 and 40 or more, the risk increases by five-, eight-, 16- and 30-fold, respectively, over that of people who have never smoked. Thus, with approximately 35% current smokers and 25% former smokers among Nordic men in 1985 and approximately 30% current smokers and 15% former smokers among Nordic women in that year, by the year 2000 10,000 cases of lung cancer (6,500 in men and 3,500 in women) will be caused by active smoking; this is equivalent to 82% of all cases of lung cancer in these populations. Another 6,000 cancers of other types (4,000 in men and 2,000 in women) are caused annually by active smoking, yielding a total of 16,000 new cases each year around the turn of the century. This implies that 14% (19% in men and 9% in women) of all incident cancers in the Nordic countries around the year 2000 will be caused by active tobacco smoking. In comparison, passive smoking is a minor cause of lung cancer, responsible for approximately 0.6% of all new cases (approximately 70 cases annually) in this area around the turn of the century.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9462818

Source DB:  PubMed          Journal:  APMIS Suppl        ISSN: 0903-465X


  8 in total

1.  Cancer risk in persons with oral cleft--a population-based study of 8,093 cases.

Authors:  Camilla Bille; Jeanette Falck Winther; Andrea Bautz; Jeffrey C Murray; Jørn Olsen; Kaare Christensen
Journal:  Am J Epidemiol       Date:  2005-06-01       Impact factor: 4.897

2.  Comparing smoking and smoking cessation process in the Republic of Karelia, Russia and North Karelia, Finland.

Authors:  T Laatikainen; E Vartiainen; P Puska
Journal:  J Epidemiol Community Health       Date:  1999-09       Impact factor: 3.710

3.  Increase of regional total cancer incidence in north Sweden due to the Chernobyl accident?

Authors:  Martin Tondel; Peter Hjalmarsson; Lennart Hardell; Göran Carlsson; Olav Axelson
Journal:  J Epidemiol Community Health       Date:  2004-12       Impact factor: 3.710

4.  Arsenic concentrations in well water and risk of bladder and kidney cancer in Finland.

Authors:  P Kurttio; E Pukkala; H Kahelin; A Auvinen; J Pekkanen
Journal:  Environ Health Perspect       Date:  1999-09       Impact factor: 9.031

5.  Cancer risk among users of neuroleptic medication: a population-based cohort study.

Authors:  S O Dalton; C Johansen; A H Poulsen; M Nørgaard; H T Sørensen; J K McLaughlin; P B Mortensen; S Friis
Journal:  Br J Cancer       Date:  2006-08-22       Impact factor: 7.640

6.  Adjustment for tobacco smoking and alcohol consumption by simultaneous analysis of several types of cancer.

Authors:  Tor Haldorsen; Jan Ivar Martinsen; Kristina Kjærheim; Tom K Grimsrud
Journal:  Cancer Causes Control       Date:  2017-02-02       Impact factor: 2.506

7.  Risk of second primary Cancer among bladder Cancer patients: a population-based cohort study in Korea.

Authors:  Whi-An Kwon; Jae Young Joung; Jiwon Lim; Chang-Mo Oh; Kyu-Won Jung; Sung Han Kim; Ho Kyung Seo; Weon Seo Park; Jinsoo Chung; Kang Hyun Lee; Young-Joo Won
Journal:  BMC Cancer       Date:  2018-05-31       Impact factor: 4.430

8.  Occupational variation in incidence of bladder cancer: a comparison of population-representative cohorts from Nordic countries and Canada.

Authors:  Kishor Hadkhale; Jill MacLeod; Paul A Demers; Jan Ivar Martinsen; Elisabete Weiderpass; Kristina Kjaerheim; Elsebeth Lynge; Pär Sparen; Laufey Tryggvadottir; M Anne Harris; Michael Tjepkema; Paul A Peters; Eero Pukkala
Journal:  BMJ Open       Date:  2017-08-04       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.